This week’s Streetwise looks at the new VLCC venture that’s starting in Oslo but may be heading across the Atlantic Even before the election of US President Donald Trump last November, talk was ...
BioMarin's Roctavian gene therapy shows long-term effectiveness in treating severe hemophilia A, reducing bleeding and improving quality of life for patients. New five-year results from the phase 3 ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most undervalued US stocks according to analysts. On June 24, BioMarin Pharmaceutical Inc. presented new 5-year data from its Phase 3 GENEr8-1 ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most undervalued US stocks according to analysts. On June 24, BioMarin Pharmaceutical Inc. presented new 5-year data from its Phase 3 GENEr8-1 ...
(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) Tuesday announced new data underscoring the long-term efficacy and safety of Roctavian (valoctocogene roxaparvovec-rvox). The Phase 3 GENEr8-1 trial ...
MELBOURNE, Australia--(BUSINESS WIRE)--Diversity Atlas, the world’s leading diversity data analytics platform which was born out of Cultural Infusion, announced a ...
Gener8 appoints Allen Pierce as CEO to lead growth in life sciences and medtech, leveraging his deep industry and leadership experience. I am extremely pleased to have a professional of the caliber of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results